New hair loss cream shows promise in large trial
Disease control
Completed
This study tested a topical solution called clascoterone against a placebo in 762 men with mild to moderate male pattern baldness. The goal was to see if it safely increases hair count and improves hair coverage over 12 months. Participants applied the solution twice daily to bal…
Phase: PHASE3 • Sponsor: Cassiopea SpA • Aim: Disease control
Last updated May 02, 2026 08:07 UTC